Insulet (PODD) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.28% |
| Dec 31, 2025 | 12.33% |
| Sep 30, 2025 | 11.83% |
| Jun 30, 2025 | 17.96% |
| Mar 31, 2025 | 19.34% |
| Dec 31, 2024 | 14.65% |
| Sep 30, 2024 | 14.81% |
| Jun 30, 2024 | 14.42% |
| Mar 31, 2024 | 12.56% |
| Dec 31, 2023 | 11.39% |
| Sep 30, 2023 | 12.99% |
| Jun 30, 2023 | 13.62% |
| Mar 31, 2023 | 27.35% |
| Dec 31, 2022 | 25.35% |
| Sep 30, 2022 | 19.53% |
| Jun 30, 2022 | 29.30% |
| Mar 31, 2022 | 29.51% |
| Dec 31, 2021 | 30.18% |
| Sep 30, 2021 | 31.14% |
| Jun 30, 2021 | 31.87% |
| Mar 31, 2021 | 30.41% |
| Dec 31, 2020 | 31.87% |
| Sep 30, 2020 | 50.65% |
| Jun 30, 2020 | 52.43% |
| Mar 31, 2020 | 35.55% |
| Dec 31, 2019 | 35.77% |
| Sep 30, 2019 | 40.93% |
| Jun 30, 2019 | 54.90% |
| Mar 31, 2019 | 55.21% |
| Dec 31, 2018 | 50.01% |
| Sep 30, 2018 | 44.60% |
| Jun 30, 2018 | 40.82% |
| Mar 31, 2018 | 39.49% |
| Dec 31, 2017 | 40.07% |
| Sep 30, 2017 | 18.43% |
| Jun 30, 2017 | 12.18% |
| Mar 31, 2017 | 15.53% |
| Dec 31, 2016 | 16.61% |
| Sep 30, 2016 | 16.11% |
| Jun 30, 2016 | -2.77% |
| Mar 31, 2016 | -3.20% |
| Dec 31, 2015 | 11.58% |
| Sep 30, 2015 | 12.96% |
| Jun 30, 2015 | 13.83% |
| Mar 31, 2015 | 12.33% |
| Dec 31, 2014 | 10.32% |
| Sep 30, 2014 | 9.67% |
| Jun 30, 2014 | 10.86% |
| Dec 31, 2013 | 22.61% |